Proposed CMS Changes to 340B Drug Reimbursement Rates for 2027
CMS proposes to cut 340B drug reimbursement rates for 2027, seeking to align payments with actual acquisition costs and reduce expenditures by $5.7 billion.
CMS Finalizes 2026 Medicare OPPS and ASC Payment Rule with Site-neutral and Transparency Updates
CMS finalizes 2026 Medicare OPPS and ASC payment rule introducing site-neutral payments, enhanced price transparency, and updated digital health policies to modernize outpatient care reimbursement.
CMS Finalizes 2026 Payment Updates and Policy Changes for OPPS and ASCs
CMS announces 2026 updates for OPPS and ASC payment systems, including expanded site neutral payments, skin substitute product unbundling, IPO list phase-out, and new hospital price transparency requirements.